SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (6377)4/12/1999 11:06:00 AM
From: Alan Newman  Read Replies (2) | Respond to of 7041
 
Is the fact that Oppenheimer reduced estimates widely publicized?
Do you have a link?

Alan



To: Linda Kaplan who wrote (6377)4/12/1999 11:30:00 AM
From: Don Pueblo  Read Replies (1) | Respond to of 7041
 
I have no position in ZONA and never have. I just wanted to talk to Cheech. Good luck, Linda, I'm gone.



To: Linda Kaplan who wrote (6377)4/12/1999 4:36:00 PM
From: biodoc  Read Replies (1) | Respond to of 7041
 
Well Oppenheimer clearly doesn't realize that the FDA is greatly reducing the number of agents it takes to an advisory committee. They currently are only taking those for which there is an issue. If the Agency believes it is clear-cut one way or the other they will decide without an advisory committee meeting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News